Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids
Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Oxidized phospholipids (OxPL) are the major pathogenic component of oxidized low-density lipoproteins (OxLDL). Endogenous anti-OxPL activity, defined as the ability to neutralize adverse effects of oxidized lipids, may have biomarker potential.
Using two anti-OxPL monoclonal antibodies (commercial mAB-E06 and custom mAB-509) we developed a novel...
Alternative Titles
Full title
Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1811887207
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1811887207
Other Identifiers
ISSN
1752-0363
E-ISSN
1752-0371
DOI
10.2217/bmm-2016-0096
